After receiving IL13Rα2-CAR T cell therapy, a patient with recurrent multifocal glioblastoma experienced dramatic improvements in his quality of life, including the discontinuation of systemic glucocorticoids and a return to normal life activities. The gene discussed is IL13RA2; the disease is glioblastoma.